Melanoma Updates Potential Toxicities Associated with Immunotherapy in the Treatment of Melanoma
Jan 24, 2022 ·
6m 35s
Sign up for free
Listen to this episode and many more. Enjoy the best podcasts on Spreaker!
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
Dr. Douglas Johnson discusses the potential toxicities that are associated with immunotherapy in melanoma patients. Meredith McKean MD, MPH with Sarah Cannon Research Institute, Douglas Johnson, MD, Assistant Professor of...
show more
Dr. Douglas Johnson discusses the potential toxicities that are associated with immunotherapy in melanoma patients.
Meredith McKean MD, MPH with Sarah Cannon Research Institute, Douglas Johnson, MD, Assistant Professor of Medicine at Vanderbilt, and Roman Groisberg, MD Medical Oncologist at Rutgers Health joined GRACE to discuss current updates in treatment for Melanoma.
A huge thank you to our sponsors #Merck and #Exelixis!
For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
show less
Meredith McKean MD, MPH with Sarah Cannon Research Institute, Douglas Johnson, MD, Assistant Professor of Medicine at Vanderbilt, and Roman Groisberg, MD Medical Oncologist at Rutgers Health joined GRACE to discuss current updates in treatment for Melanoma.
A huge thank you to our sponsors #Merck and #Exelixis!
For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
Information
| Author | cancerGRACE |
| Organization | cancerGRACE |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
